Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models

Ying Li(Zhejiang University), Jianqing Gao(Zhejiang University), Jian You(Zhejiang University), Meng Wang(Chinese Academy of Sciences), Pei Zhi(Zhejiang University)
Oncotarget
December 8, 2017
Cited by 70


Related Papers